Browse > Article
http://dx.doi.org/10.5483/BMBRep.2019.52.12.282

The role of cell type-specific mitochondrial dysfunction in the pathogenesis of Alzheimer's disease  

Kim, Dong Kyu (Department of Biomedical Sciences, College of Medicine, Seoul National University)
MookJung, Inhee (Department of Biomedical Sciences, College of Medicine, Seoul National University)
Publication Information
BMB Reports / v.52, no.12, 2019 , pp. 679-688 More about this Journal
Abstract
The decrease of metabolism in the brain has been observed as the important lesions of Alzheimer's disease (AD) from the early stages of diagnosis. The cumulative evidence has reported that the failure of mitochondria, an organelle involved in diverse biological processes as well as energy production, maybe the cause or effect of the pathogenesis of AD. Both amyloid and tau pathologies have an impact upon mitochondria through physical interaction or indirect signaling pathways, resulting in the disruption of mitochondrial function and dynamics which can trigger AD. In addition, mitochondria are involved in different biological processes depending on the specific functions of each cell type in the brain. Thus, it is necessary to understand mitochondrial dysfunction as part of the pathological phenotypes of AD according to each cell type. In this review, we summarize that 1) the effects of AD pathology inducing mitochondrial dysfunction and 2) the contribution of mitochondrial dysfunction in each cell type to AD pathogenesis.
Keywords
Alzheimer's Disease; Bioenergetic Defects; Mitochondria; Mitochondrial Dynamics; Mitochondrial Dysfunction;
Citations & Related Records
연도 인용수 순위
  • Reference
1 Gazit N, Vertkin I, Shapira I et al (2016) IGF-1 Receptor Differentially Regulates Spontaneous and Evoked Transmission via Mitochondria at Hippocampal Synapses. Neuron 89, 583-597   DOI
2 Moloney AM, Griffin RJ, Timmons S, O'Connor R, Ravid R and O'Neill C (2010) Defects in IGF-1 receptor, insulin receptor and IRS-1/2 in Alzheimer's disease indicate possible resistance to IGF-1 and insulin signalling. Neurobiol Aging 31, 224-243   DOI
3 Zhang B, Tang XC and Zhang HY (2013) Alternations of central insulin-like growth factor-1 sensitivity in APP/PS1 transgenic mice and neuronal models. J Neurosci Res 91, 717-725   DOI
4 Allen NJ and Eroglu C (2017) Cell Biology of Astrocyte-Synapse Interactions. Neuron 96, 697-708   DOI
5 Rose CF, Verkhratsky A and Parpura V (2013) Astrocyte glutamine synthetase: pivotal in health and disease. Biochem Soc Trans 41, 1518-1524   DOI
6 Jackson JG, O'Donnell JC, Takano H, Coulter DA and Robinson MB (2014) Neuronal activity and glutamate uptake decrease mitochondrial mobility in astrocytes and position mitochondria near glutamate transporters. J Neurosci 34, 1613-1624   DOI
7 Xu NJ, Bao L, Fan HP et al (2003) Morphine withdrawal increases glutamate uptake and surface expression of glutamate transporter GLT1 at hippocampal synapses. J Neurosci 23, 4775-4784   DOI
8 Genda EN, Jackson JG, Sheldon AL et al (2011) Co-compartmentalization of the astroglial glutamate transporter, GLT-1, with glycolytic enzymes and mitochondria. J Neurosci 31, 18275-18288   DOI
9 Canals S, Larrosa B, Pintor J, Mena MA and Herreras O (2008) Metabolic challenge to glia activates an adenosine-mediated safety mechanism that promotes neuronal survival by delaying the onset of spreading depression waves. J Cereb Blood Flow Metab 28, 1835-1844   DOI
10 Belanger M, Allaman I and Magistretti PJ (2011) Brain energy metabolism: focus on astrocyte-neuron metabolic cooperation. Cell Metab 14, 724-738   DOI
11 Bouzier-Sore AK and Pellerin L (2013) Unraveling the complex metabolic nature of astrocytes. Front Cell Neurosci 7, 179   DOI
12 Fu W, Shi D, Westaway D and Jhamandas JH (2015) Bioenergetic mechanisms in astrocytes may contribute to amyloid plaque deposition and toxicity. J Biol Chem 290, 12504-12513   DOI
13 Ebert D, Haller RG and Walton ME (2003) Energy contribution of octanoate to intact rat brain metabolism measured by 13C nuclear magnetic resonance spectroscopy. J Neurosci 23, 5928-5935   DOI
14 Jones VC, Atkinson-Dell R, Verkhratsky A and Mohamet L (2017) Aberrant iPSC-derived human astrocytes in Alzheimer's disease. Cell Death Dis 8, e2696   DOI
15 Oksanen M, Petersen AJ, Naumenko N et al (2017) PSEN1 Mutant iPSC-Derived Model Reveals Severe Astrocyte Pathology in Alzheimer's Disease. Stem Cell Reports 9, 1885-1897   DOI
16 Sekar S, McDonald J, Cuyugan L et al (2015) Alzheimer's disease is associated with altered expression of genes involved in immune response and mitochondrial processes in astrocytes. Neurobiol Aging 36, 583-591   DOI
17 Myung NH, Zhu X, Kruman, II et al (2008) Evidence of DNA damage in Alzheimer disease: phosphorylation of histone H2AX in astrocytes. Age (Dordr) 30, 209-215   DOI
18 David DC, Hauptmann S, Scherping I et al (2005) Proteomic and functional analyses reveal a mitochondrial dysfunction in P301L tau transgenic mice. J Biol Chem 280, 23802-23814   DOI
19 Rhein V, Baysang G, Rao S et al (2009) Amyloid-beta leads to impaired cellular respiration, energy production and mitochondrial electron chain complex activities in human neuroblastoma cells. Cell Mol Neurobiol 29, 1063-1071   DOI
20 Beck SJ, Guo L, Phensy A et al (2016) Deregulation of mitochondrial F1FO-ATP synthase via OSCP in Alzheimer's disease. Nat Commun 7, 11483   DOI
21 Schulz KL, Eckert A, Rhein V et al (2012) A new link to mitochondrial impairment in tauopathies. Mol Neurobiol 46, 205-216   DOI
22 Rhein V, Song X, Wiesner A et al (2009) Amyloid-beta and tau synergistically impair the oxidative phosphorylation system in triple transgenic Alzheimer's disease mice. Proc Natl Acad Sci U S A 106, 20057-20062   DOI
23 Manczak M, Anekonda TS, Henson E, Park BS, Quinn J and Reddy PH (2006) Mitochondria are a direct site of A beta accumulation in Alzheimer's disease neurons: implications for free radical generation and oxidative damage in disease progression. Hum Mol Genet 15, 1437-1449   DOI
24 Kim C, Choi H, Jung ES et al (2012) HDAC6 inhibitor blocks amyloid beta-induced impairment of mitochondrial transport in hippocampal neurons. PLoS One 7, e42983   DOI
25 Kandimalla R, Manczak M, Fry D, Suneetha Y, Sesaki H and Reddy PH (2016) Reduced dynamin-related protein 1 protects against phosphorylated Tau-induced mitochondrial dysfunction and synaptic damage in Alzheimer's disease. Hum Mol Genet 25, 4881-4897
26 Perez MJ, Vergara-Pulgar K, Jara C, Cabezas-Opazo F and Quintanilla RA (2018) Caspase-Cleaved Tau Impairs Mitochondrial Dynamics in Alzheimer's Disease. Mol Neurobiol 55, 1004-1018   DOI
27 Byun J, Son SM, Cha MY et al (2015) CR6-interacting factor 1 is a key regulator in Abeta-induced mitochondrial disruption and pathogenesis of Alzheimer's disease. Cell Death Differ 22, 959-973   DOI
28 Shahpasand K, Uemura I, Saito T et al (2012) Regulation of mitochondrial transport and inter-microtubule spacing by tau phosphorylation at the sites hyperphosphorylated in Alzheimer's disease. J Neurosci 32, 2430-2441   DOI
29 Kopeikina KJ, Carlson GA, Pitstick R et al (2011) Tau accumulation causes mitochondrial distribution deficits in neurons in a mouse model of tauopathy and in human Alzheimer's disease brain. Am J Pathol 179, 2071-2082   DOI
30 Stamer K, Vogel R, Thies E, Mandelkow E and Mandelkow EM (2002) Tau blocks traffic of organelles, neurofilaments, and APP vesicles in neurons and enhances oxidative stress. J Cell Biol 156, 1051-1063   DOI
31 Vos M, Lauwers E and Verstreken P (2010) Synaptic mitochondria in synaptic transmission and organization of vesicle pools in health and disease. Front Synaptic Neurosci 2, 139   DOI
32 Caspersen C, Wang N, Yao J et al (2005) Mitochondrial Abeta: a potential focal point for neuronal metabolic dysfunction in Alzheimer's disease. FASEB J 19, 2040-2041   DOI
33 Devi L, Prabhu BM, Galati DF, Avadhani NG and Anandatheerthavarada HK (2006) Accumulation of amyloid precursor protein in the mitochondrial import channels of human Alzheimer's disease brain is associated with mitochondrial dysfunction. J Neurosci 26, 9057-9068   DOI
34 Hansson Petersen CA, Alikhani N, Behbahani H et al (2008) The amyloid beta-peptide is imported into mitochondria via the TOM import machinery and localized to mitochondrial cristae. Proc Natl Acad Sci U S A 105, 13145-13150   DOI
35 Fecher C, Trovo L, Muller SA et al (2019) Cell-typespecific profiling of brain mitochondria reveals functional and molecular diversity. Nat Neurosci 22, 1731-1742   DOI
36 Ioannou MS, Jackson J, Sheu SH et al (2019) Neuron-Astrocyte Metabolic Coupling Protects against Activity-Induced Fatty Acid Toxicity. Cell 177, 1522-1535 e1514   DOI
37 Park J, Choi H, Min JS et al (2013) Mitochondrial dynamics modulate the expression of pro-inflammatory mediators in microglial cells. J Neurochem 127, 221-232   DOI
38 Orihuela R, McPherson CA and Harry GJ (2016) Microglial M1/M2 polarization and metabolic states. Br J Pharmacol 173, 649-665   DOI
39 Davey GP, Peuchen S and Clark JB (1998) Energy thresholds in brain mitochondria. Potential involvement in neurodegeneration. J Biol Chem 273, 12753-12757   DOI
40 Brown MR, Sullivan PG and Geddes JW (2006) Synaptic mitochondria are more susceptible to Ca2+overload than nonsynaptic mitochondria. J Biol Chem 281, 11658-11668   DOI
41 Zott B, Simon MM, Hong W et al (2019) A vicious cycle of beta amyloid-dependent neuronal hyperactivation. Science 365, 559-565   DOI
42 Du H, Guo L, Yan S, Sosunov AA, McKhann GM and Yan SS (2010) Early deficits in synaptic mitochondria in an Alzheimer's disease mouse model. Proc Natl Acad Sci U S A 107, 18670-18675   DOI
43 Abeti R, Abramov AY and Duchen MR (2011) Beta-amyloid activates PARP causing astrocytic metabolic failure and neuronal death. Brain 134, 1658-1672   DOI
44 Simpson JE, Ince PG, Haynes LJ et al (2010) Population variation in oxidative stress and astrocyte DNA damage in relation to Alzheimer-type pathology in the ageing brain. Neuropathol Appl Neurobiol 36, 25-40   DOI
45 Lee HP, Pancholi N, Esposito L et al (2012) Early induction of oxidative stress in mouse model of Alzheimer disease with reduced mitochondrial superoxide dismutase activity. PLoS One 7, e28033   DOI
46 Sarkar P, Zaja I, Bienengraeber M et al (2014) Epoxyeicosatrienoic acids pretreatment improves amyloid beta-induced mitochondrial dysfunction in cultured rat hippocampal astrocytes. Am J Physiol Heart Circ Physiol 306, H475-484   DOI
47 Abramov AY, Canevari L and Duchen MR (2004) Beta-amyloid peptides induce mitochondrial dysfunction and oxidative stress in astrocytes and death of neurons through activation of NADPH oxidase. J Neurosci 24, 565-575   DOI
48 Culmsee C, Michels S, Scheu S, Arolt V, Dannlowski U and Alferink J (2018) Mitochondria, Microglia, and the Immune System-How Are They Linked in Affective Disorders? Front Psychiatry 9, 739   DOI
49 Baik SH, Kang S, Lee W et al (2019) A Breakdown in Metabolic Reprogramming Causes Microglia Dysfunction in Alzheimer's Disease. Cell Metab 30, 493-507 e496   DOI
50 Konttinen H, Cabral-da-Silva MEC, Ohtonen S et al (2019) PSEN1DeltaE9, APPswe, and APOE4 Confer Disparate Phenotypes in Human iPSC-Derived Microglia. Stem Cell Reports 13, 669-683   DOI
51 Cha MY, Cho HJ, Kim C et al (2015) Mitochondrial ATP synthase activity is impaired by suppressed OGlcNAcylation in Alzheimer's disease. Hum Mol Genet 24, 6492-6504   DOI
52 Querfurth HW and LaFerla FM (2010) Alzheimer's disease. N Engl J Med 362, 329-344   DOI
53 Cao J, Hou J, Ping J and Cai D (2018) Advances in developing novel therapeutic strategies for Alzheimer's disease. Mol Neurodegener 13, 64   DOI
54 Sanabria-Castro A, Alvarado-Echeverria I and Monge-Bonilla C (2017) Molecular Pathogenesis of Alzheimer's Disease: An Update. Ann Neurosci 24, 46-54   DOI
55 Han SH, Park JC and Mook-Jung I (2016) Amyloid beta-interacting partners in Alzheimer's disease: From accomplices to possible therapeutic targets. Prog Neurobiol 137, 17-38   DOI
56 Yoshida M, Muneyuki E and Hisabori T (2001) ATP synthase--a marvellous rotary engine of the cell. Nat Rev Mol Cell Biol 2, 669-677   DOI
57 Halestrap A (2005) Biochemistry: a pore way to die. Nature 434, 578-579   DOI
58 Nicotra A and Parvez S (2002) Apoptotic molecules and MPTP-induced cell death. Neurotoxicol Teratol 24, 599-605   DOI
59 Jadiya P, Kolmetzky DW, Tomar D et al (2019) Impaired mitochondrial calcium efflux contributes to disease progression in models of Alzheimer's disease. Nat Commun 10, 3885   DOI
60 Pickett EK, Rose J, McCrory C et al (2018) Regionspecific depletion of synaptic mitochondria in the brains of patients with Alzheimer's disease. Acta Neuropathol 136, 747-757   DOI
61 Lee SH, Kim KR, Ryu SY et al (2012) Impaired short-term plasticity in mossy fiber synapses caused by mitochondrial dysfunction of dentate granule cells is the earliest synaptic deficit in a mouse model of Alzheimer's disease. J Neurosci 32, 5953-5963   DOI
62 Vogtle FN, Wortelkamp S, Zahedi RP et al (2009) Global analysis of the mitochondrial N-proteome identifies a processing peptidase critical for protein stability. Cell 139, 428-439   DOI
63 Ulland TK, Song WM, Huang SC et al (2017) TREM2 Maintains Microglial Metabolic Fitness in Alzheimer's Disease. Cell 170, 649-663 e613   DOI
64 Zamzami N, Larochette N and Kroemer G (2005) Mitochondrial permeability transition in apoptosis and necrosis. Cell Death Differ 12 Suppl 2, 1478-1480   DOI
65 Javadov S and Kuznetsov A (2013) Mitochondrial permeability transition and cell death: the role of cyclophilin d. Front Physiol 4, 76
66 Du H, Guo L, Fang F et al (2008) Cyclophilin D deficiency attenuates mitochondrial and neuronal perturbation and ameliorates learning and memory in Alzheimer's disease. Nat Med 14, 1097-1105   DOI
67 Lustbader JW, Cirilli M, Lin C et al (2004) ABAD directly links Abeta to mitochondrial toxicity in Alzheimer's disease. Science 304, 448-452   DOI
68 Chen JX and Yan SS (2010) Role of mitochondrial amyloid-beta in Alzheimer's disease. J Alzheimers Dis 20 Suppl 2, S569-578   DOI
69 Joshi AU, Minhas PS, Liddelow SA et al (2019) Fragmented mitochondria released from microglia trigger A1 astrocytic response and propagate inflammatory neurodegeneration. Nat Neurosci 22, 1635-1648   DOI
70 Marcus C, Mena E and Subramaniam RM (2014) Brain PET in the diagnosis of Alzheimer's disease. Clin Nucl Med 39, e413-422; quiz e423-416   DOI
71 Fang EF, Hou Y, Palikaras K et al (2019) Mitophagy inhibits amyloid-beta and tau pathology and reverses cognitive deficits in models of Alzheimer's disease. Nat Neurosci 22, 401-412   DOI
72 Mancuso M, Calsolaro V, Orsucci D et al (2009) Mitochondria, cognitive impairment, and Alzheimer's disease. Int J Alzheimers Dis 2009, 951548
73 Mosconi L, Berti V, Glodzik L, Pupi A, De Santi S and de Leon MJ (2010) Pre-clinical detection of Alzheimer's disease using FDG-PET, with or without amyloid imaging. J Alzheimers Dis 20, 843-854   DOI
74 Patel JR and Brewer GJ (2003) Age-related changes in neuronal glucose uptake in response to glutamate and beta-amyloid. J Neurosci Res 72, 527-536   DOI
75 Beal MF (1995) Aging, energy, and oxidative stress in neurodegenerative diseases. Ann Neurol 38, 357-366   DOI
76 Zhu X, Perry G, Smith MA and Wang X (2013) Abnormal mitochondrial dynamics in the pathogenesis of Alzheimer's disease. J Alzheimers Dis 33 Suppl 1, S253-262
77 Wang X, Su B, Zheng L, Perry G, Smith MA and Zhu X (2009) The role of abnormal mitochondrial dynamics in the pathogenesis of Alzheimer's disease. J Neurochem 109 Suppl 1, 153-159   DOI
78 Swerdlow RH (2018) Mitochondria and Mitochondrial Cascades in Alzheimer's Disease. J Alzheimers Dis 62, 1403-1416   DOI
79 Swerdlow RH, Burns JM and Khan SM (2010) The Alzheimer's disease mitochondrial cascade hypothesis. J Alzheimers Dis 20 Suppl 2, S265-279   DOI
80 Swerdlow RH, Burns JM and Khan SM (2014) The Alzheimer's disease mitochondrial cascade hypothesis: progress and perspectives. Biochim Biophys Acta 1842, 1219-1231   DOI
81 Cheng Y and Bai F (2018) The Association of Tau With Mitochondrial Dysfunction in Alzheimer's Disease. Front Neurosci 12, 163   DOI
82 Zhang L, Trushin S, Christensen TA et al (2016) Altered brain energetics induces mitochondrial fission arrest in Alzheimer's Disease. Sci Rep 6, 18725   DOI
83 Mossmann D, Vogtle FN, Taskin AA et al (2014) Amyloid-beta peptide induces mitochondrial dysfunction by inhibition of preprotein maturation. Cell Metab 20, 662-669   DOI
84 Mishra P and Chan DC (2016) Metabolic regulation of mitochondrial dynamics. J Cell Biol 212, 379-387   DOI
85 Youle RJ and van der Bliek AM (2012) Mitochondrial fission, fusion, and stress. Science 337, 1062-1065   DOI
86 Trushina E (2016) A shape shifting organelle: unusual mitochondrial phenotype determined with threedimensional electron microscopy reconstruction. Neural Regen Res 11, 900-901
87 Shah SI, Paine JG, Perez C and Ullah G (2019) Mitochondrial fragmentation and network architecture in degenerative diseases. PLoS One 14, e0223014   DOI
88 Wang X, Su B, Lee HG et al (2009) Impaired balance of mitochondrial fission and fusion in Alzheimer's disease. J Neurosci 29, 9090-9103   DOI
89 Tyumentsev MA, Stefanova NA, Kiseleva EV and Kolosova NG (2018) Mitochondria with Morphology Characteristic for Alzheimer's Disease Patients Are Found in the Brain of OXYS Rats. Biochemistry (Mosc) 83, 1083-1088   DOI
90 Xie H, Guan J, Borrelli LA, Xu J, Serrano-Pozo A and Bacskai BJ (2013) Mitochondrial alterations near amyloid plaques in an Alzheimer's disease mouse model. J Neurosci 33, 17042-17051   DOI
91 Perez MJ, Ponce DP, Osorio-Fuentealba C, Behrens MI and Quintanilla RA (2017) Mitochondrial Bioenergetics Is Altered in Fibroblasts from Patients with Sporadic Alzheimer's Disease. Front Neurosci 11, 553   DOI
92 Zhang C, Rissman RA and Feng J (2015) Characterization of ATP alternations in an Alzheimer's disease transgenic mouse model. J Alzheimers Dis 44, 375-378   DOI
93 Lee SH, Lutz D, Mossalam M, Bolshakov VY, Frotscher M and Shen J (2017) Presenilins regulate synaptic plasticity and mitochondrial calcium homeostasis in the hippocampal mossy fiber pathway. Mol Neurodegener 12, 48   DOI
94 Szablewski L (2017) Glucose Transporters in Brain: In Health and in Alzheimer's Disease. J Alzheimers Dis 55, 1307-1320   DOI
95 Sun J, Feng X, Liang D, Duan Y and Lei H (2012) Down-regulation of energy metabolism in Alzheimer's disease is a protective response of neurons to the microenvironment. J Alzheimers Dis 28, 389-402   DOI
96 Sonntag KC, Ryu WI, Amirault KM et al (2017) Late-onset Alzheimer's disease is associated with inherent changes in bioenergetics profiles. Sci Rep 7, 14038   DOI
97 Carvalho C, Cardoso S, Correia SC et al (2012) Metabolic alterations induced by sucrose intake and Alzheimer's disease promote similar brain mitochondrial abnormalities. Diabetes 61, 1234-1242   DOI
98 Cha MY, Han SH, Son SM et al (2012) Mitochondriaspecific accumulation of amyloid beta induces mitochondrial dysfunction leading to apoptotic cell death. PLoS One 7, e34929   DOI
99 Keeney JT, Ibrahimi S and Zhao L (2015) Human ApoE Isoforms Differentially Modulate Glucose and Amyloid Metabolic Pathways in Female Brain: Evidence of the Mechanism of Neuroprotection by ApoE2 and Implications for Alzheimer's Disease Prevention and Early Intervention. J Alzheimers Dis 48, 411-424   DOI
100 Wu L, Zhang X and Zhao L (2018) Human ApoE Isoforms Differentially Modulate Brain Glucose and Ketone Body Metabolism: Implications for Alzheimer's Disease Risk Reduction and Early Intervention. J Neurosci 38, 6665-6681   DOI
101 Reddy PH and Beal MF (2008) Amyloid beta, mitochondrial dysfunction and synaptic damage: implications for cognitive decline in aging and Alzheimer's disease. Trends Mol Med 14, 45-53   DOI
102 Wang X, Su B, Siedlak SL et al (2008) Amyloid-beta overproduction causes abnormal mitochondrial dynamics via differential modulation of mitochondrial fission/fusion proteins. Proc Natl Acad Sci U S A 105, 19318-19323   DOI
103 Manczak M, Calkins MJ and Reddy PH (2011) Impaired mitochondrial dynamics and abnormal interaction of amyloid beta with mitochondrial protein Drp1 in neurons from patients with Alzheimer's disease: implications for neuronal damage. Hum Mol Genet 20, 2495-2509   DOI
104 Joshi AU, Saw NL, Shamloo M and Mochly-Rosen D (2018) Drp1/Fis1 interaction mediates mitochondrial dysfunction, bioenergetic failure and cognitive decline in Alzheimer's disease. Oncotarget 9, 6128-6143   DOI
105 Baek SH, Park SJ, Jeong JI et al (2017) Inhibition of Drp1 Ameliorates Synaptic Depression, Abeta Deposition, and Cognitive Impairment in an Alzheimer's Disease Model. J Neurosci 37, 5099-5110   DOI
106 Knott AB, Perkins G, Schwarzenbacher R and Bossy-Wetzel E (2008) Mitochondrial fragmentation in neurodegeneration. Nat Rev Neurosci 9, 505-518   DOI
107 Westermann B (2009) Nitric oxide links mitochondrial fission to Alzheimer's disease. Sci Signal 2, pe29
108 Cho DH, Nakamura T, Fang J et al (2009) S-nitrosylation of Drp1 mediates beta-amyloid-related mitochondrial fission and neuronal injury. Science 324, 102-105   DOI
109 Kang S, Byun J, Son SM and Mook-Jung I (2018) Thrombospondin-1 protects against Abeta-induced mitochondrial fragmentation and dysfunction in hippocampal cells. Cell Death Discov 4, 31   DOI
110 Manczak M and Reddy PH (2012) Abnormal interaction between the mitochondrial fission protein Drp1 and hyperphosphorylated tau in Alzheimer's disease neurons: implications for mitochondrial dysfunction and neuronal damage. Hum Mol Genet 21, 2538-2547   DOI